331 results on '"MacGregor, G"'
Search Results
2. P362 Vitamin A deficiency in the West of Scotland Adult CF Centre
3. P195 Vaping and cystic fibrosis: current perceptions and future directions
4. EPS10.08 LONGITUDE: an observational study of the long-term effectiveness of ELX/TEZ/IVA in people with CF using data from the UK CF Registry — preliminary results from the subgroup aged 6–11 years
5. Comment on: Less sodium and more potassium to reduce cardiovascular risk and the PURE study
6. EPS1.07 Impact of elexacaftor/tezacaftor/ivacaftor (ETI) therapy on Aspergillus fumigatus serology in adults with cystic fibrosis
7. 264: CF Active—Introducing alternative exercise professionals to support work done by clinicians in enhancing exercise habits of people with CF
8. P115 The diagnosis and monitoring of cystic fibrosis liver disease in a west of Scotland CF cohort
9. PRS31 Modelling Survival of People with Cystic Fibrosis (PWCF) Aged ≥12 YEARS Homozygous for the F508DEL Mutation Treated with Ivacaftor/Tezacaftor/Elexacaftor and Ivacaftor (IVA/TEZ/ELX)
10. PRS2 Modelling Survival of People with Cystic Fibrosis (PWCF) Aged ≥12 YEARS Heterozygous for the F508DEL Mutation with a Minimal Function Mutation Treated with Ivacaftor/Tezacaftor/Elexacaftor and Ivacaftor (IVA/TEZ/ELX)
11. Dietary salt, high blood pressure and other harmful effects on health
12. Scientific basis for reducing the salt (sodium) content in food products
13. P1691Impact of dose and duration of dietary salt reduction on blood pressure levels: systematic review and meta-analysis of randomised trials
14. Long-Term Reduction in Sodium Balance: Possible Additional Mechanism Whereby Nifedipine Lowers Blood Pressure
15. Identification and characterisation of Staphylococcus aureus on low cost screen printed carbon electrodes using impedance spectroscopy
16. 62 Correlated changes in inflammation biomarkers from a phase 1 study of acebilustat in adult cystic fibrosis patients
17. WS13.6 GLPG1837 in subjects with cystic fibrosis (CF) and the G551D mutation: results from a phase II study (SAPHIRA1)
18. Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis
19. 250 Patient-reported outcomes among patients (pts) with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor (IVA) compared with those homozygous for the F508del-CFTR mutation
20. ePS02.1 Advanced care planning and thinking ahead in cystic fibrosis: a quality improvement pilot project for adults with cystic fibrosis
21. 126 A phase 1 clinical study of CTX-4430 in cystic fibrosis patients
22. Food and the responsibility deal: how the salt reduction strategy was derailed
23. School based education programme to reduce salt intake in children and their families (School-EduSalt): cluster randomised controlled trial
24. A Circulating Sodium Transport Inhibitor in Essential Hypertension
25. An Increase in a Circulating Inhibitor of Na+/K+-ATPase: The Link between Sodium and Vascular Tone in Experimental and Inherited Hypertension?
26. The Relation of a Circulating Sodium Transport Inhibitor to Essential Hypertension
27. Salt and Blood Pressure
28. Sodium Chloride and Blood Pressure
29. Renin-Angiotensin-Aldosterone System in the Maintenance of Blood Pressure
30. Alteration of Sodium and Potassium Intake in the Treatment of Hypertension
31. The Natriuretic Hormone and Hypertension
32. Rolle von KATP-Kanälen bei der Ischämie intestinaler Organe
33. Raised Concentration of a Circulating Na+-K+-ATPase Inhibitor in Essential Hypertension
34. Salt Intake and Mortality
35. Performance of the LHCb Vertex Locator
36. Cross-sectional survey of salt content in cheese: a major contributor to salt intake in the UK
37. 154 Morbidity and mortality following radical radiotherapy treatment for non-small cell lung cancer
38. Salt: The Dying Echoes of the Food Industry
39. S100 Novel T helper cell responses against Pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis
40. Salt reduction in the United Kingdom: a successful experiment in public health
41. Altering plasma sodium concentration rapidly changes blood pressure during haemodialysis
42. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials
43. PO46 Young women with breast cancer do well following immediate breast reconstruction in a networked regional-tertiary service
44. 297 Health care professionals’ appreciation of the challenges of concordance to therapies in CF
45. Plasma sodium and blood pressure in individuals on haemodialysis
46. Nutrition in cardiovascular disease: salt in hypertension and heart failure
47. 148 The influence of moulds as an independent risk factor for decreasing lung function in cystic fibrosis
48. Interested in developing a national programme to reduce dietary salt?
49. ALTERING PLASMA SODIUM CONCENTRATION RAPIDLY CHANGES BLOOD PRESSURE DURING HAEMODIALYSIS: PP.23.420
50. Promoting weight gain with olanzapine in underweight adults with cystic fibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.